Trial reportBMC complementary medicine and therapies2025
Interest in complementary and alternative medicine among participants in a study on cancer prevention by green tea extract - results from an expert-based survey of MIRACLE trial participants.
Trial report in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01360320 (Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAlthough chemopreventive strategies such as acetylsalicylic acid have shown potential in cancer prevention, they also entail adverse effects. This leads to growing interest in "natural" compounds, such as plant-based extracts, which may offer preventive benefits with fewer side effects. However, little is known aboutindividuals' personal attitudes towards conventional medications and complementary or alternative therapies when they are eligible for various cancer screening and prevention programmes. The present study aims to investigate the attitude toward medications and various therapies, as well as their prescription, among subjects participating in a clinical trial on the prevention of colorectal adenomas using green tea extract. A further goal was to assess whether the study predominantly attracted individuals with a strong preference for natural products or a more diverse set of opinions.
methods992 participants (age 50-80 years) of the MIRACLE study (a randomised study comparing green tea extract vs. placebo for secondary prevention of colorectal adenomas, NCT01360320) in 40 study centres across Germany received a 25-item, expert-based questionnaire regarding their attitude towards different medications and therapies including complementary and alternative medicine. Basic characteristics including age, gender, ECOG status, and lifestyle factors were also recorded. An exploratory factor analysis was used to group the items into eight thematic areas, which were then analysed for potential associations with the participants' baseline characteristics.
resultsResponse rate to the questionnaire was 94.3% (935/992). Survey participants mainly expressed positive attitudes towards both conventional and complementary medicine. Most were open to genetic testing for personalised treatment. Comparing the categories of the exploratory factor analysis revealed that female gender and regular exercise were associated with the regular use of alternative healing methods (i.e. acupuncture or homeopathic medicine). A more favourable view of alternative approaches was more common among younger and better-educated individuals, but the same groups also rated conventional medicine less negatively.
conclusionThe findings of this study reveal a relatively high level of openness towards both conventional and alternative medicine among participants of the MIRACLE trial, as well as certain features, such as age, gender, and education that impact on the attitude towards medications and therapies among participants in a study on secondary prevention of colorectal polyps by green tea extract.
trial registrationClinicalTrials.gov: NCT01360320.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.